Sensitive detection of epidermal growth factor receptor mutations in lung cancer specimens. Identifies patients eligible for targeted tyrosine kinase inhibitor therapy.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BIOTYPE GmbH
Germany · 6 relevant products
Axbio (shenzhen) Co.,LTD
China · 2 relevant products
CheMOnitor Ltd.
Hungary · 1 relevant product
Daan Gene Co., Ltd.
China · 1 relevant product
GMA Group Trading
Egypt · 1 relevant product
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 2 relevant products
LifeOS Genomics Corporation
Taiwan · 3 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 12 relevant products
Rainsure Scientific Co. Ltd.
China · 2 relevant products
Suzhou Rainsure Scientific Co., Ltd.
China · 2 relevant products
43 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 102 closest product alternatives
BIOTYPE GmbH · Germany
Kit for fast detection of actionable somatic FGFR3 mutations in solid tumors. Enables rapid identification of FGFR3 alterations for treatment decision-making.
Axbio (shenzhen) Co.,LTD · China
Molecular diagnostic kit for cancer genomics profiling and tumor mutation analysis. Enables detection of somatic mutations relevant to oncology and cancer treatment planning.
CheMOnitor Ltd. · Hungary
Early diagnostic solution for monitoring chemotherapy effectiveness in lung cancer patients at an initial treatment stage. Uses glycan analysis to predict treatment response and enable timely clinical decision-making.
Daan Gene Co., Ltd. · China
Diagnostic kit using PCR methodology for identifying genetic mutations and polymorphisms. Supports clinical diagnosis of genetic disorders and carrier screening.
GMA Group Trading · Egypt
Molecular test for detection of epidermal growth factor receptor mutations in lung cancer diagnosis.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
PCR-based molecular diagnostic kit for detection of epidermal growth factor receptor mutations in solid tumors. Supports personalized cancer treatment planning and targeted therapy selection.
LifeOS Genomics Corporation · Taiwan
Liquid biopsy assay panel for detecting epidermal growth factor receptor (EGFR) mutations in lung cancer patients. Utilizes mdPCR technology for high-sensitivity screening and mutation identification from blood samples.
HLB PANAGENE Co., Ltd. · South Korea
A liquid biopsy diagnostic test for detection of EGFR mutations in circulating tumor DNA, supporting non-invasive lung cancer monitoring and treatment selection.
Rainsure Scientific Co. Ltd. · China
Molecular assay kit detecting EGFR gene mutations including EGFR-19del variant in tissue DNA and plasma cell-free DNA. Supports non-small cell lung cancer patient stratification and treatment selection.
Suzhou Rainsure Scientific Co., Ltd. · China
Molecular assay for detecting EGFR gene mutations including 19-deletion variant in tissue and plasma circulating free DNA. Supports treatment selection and monitoring in non-small cell lung cancer patients.
TRUPCR Europe Ltd · United Kingdom
A real-time PCR diagnostic kit for EGFR mutation detection. Used in solid tumour oncology for identifying epidermal growth factor receptor mutations in patient samples.
Genetic Tools, LLC · United States
Ultra-high sensitivity early detection kit designed to identify cancer gene mutations. Enables early-stage cancer diagnosis through advanced genetic analysis technology.
90 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products